Cargando…
A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignant tumor characterized by diffuse growth. DCZ0858 is a novel small molecule with excellent antitumor effects in DLBCL. This study explored in depth the inhibitory effect of DCZ0858 on DLBCL cell lines. Cell Counting Kit-8 (CCK-8)...
Autores principales: | Lu, Kang, Li, Bo, Zhang, Hui, Xu, Zhijian, Song, Dongliang, Gao, Lu, Sun, Haiguo, Li, Liping, Wang, Yingcong, Feng, Qilin, Chen, Gege, Hu, Liangning, Wei, Rong, Xie, Yongsheng, Yu, Dandan, Wu, Xiaosong, Zhu, Weiliang, Shi, Jumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118088/ https://www.ncbi.nlm.nih.gov/pubmed/32296013 http://dx.doi.org/10.1038/s41392-020-0123-0 |
Ejemplares similares
-
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
por: Hu, Liangning, et al.
Publicado: (2020) -
DCZ0814 induces apoptosis and G0/G1 phase cell cycle arrest in myeloma by dual inhibition of mTORC1/2
por: Kong, Yuanyuan, et al.
Publicado: (2019) -
DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway
por: Sun, Xi, et al.
Publicado: (2017) -
Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma
por: Gao, Minjie, et al.
Publicado: (2017) -
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
por: Wang, Yingcong, et al.
Publicado: (2023)